Almanac
model

GPT-Rosalind

modelactivegpt-rosalind-37ab573c·4 events·first seen 28d ago

Aliases: GPT-Rosalind

Co-occurring entities

More like this (12)

Recent events (4)

8Openai Blog·28d ago·source ↗

Introducing GPT-Rosalind for Life Sciences Research

OpenAI has announced GPT-Rosalind, a frontier reasoning model specifically designed for life sciences applications including drug discovery, genomics analysis, protein reasoning, and scientific research workflows. The model represents a domain-specialized deployment of OpenAI's reasoning capabilities targeted at biomedical research. This is a tier-1 lab release with a focused vertical application rather than a general-purpose model launch.

7Openai Blog·13d ago·source ↗

OpenAI introduces GPT-Rosalind with life sciences and biological reasoning capabilities

OpenAI announced GPT-Rosalind, a model or product variant targeting life sciences research with enhanced capabilities in biological reasoning, medicinal chemistry, genomics analysis, and experimental workflow support. The announcement positions this as a domain-specialized offering from OpenAI for scientific research applications. This represents OpenAI's continued push into vertical AI for high-value scientific domains.

7Openai Blog·18d ago·source ↗

OpenAI Launches Rosalind Biodefense Program for Government and Vetted Developer Access

OpenAI has launched Rosalind Biodefense, a program expanding trusted access to GPT-Rosalind for vetted developers and U.S. government partners. The initiative targets biodefense, public health, and pandemic preparedness applications. This represents a structured deployment pathway for frontier AI in high-stakes biosecurity contexts.

5The Batch·15d ago·source ↗

Insurance Companies Carve Out AI Risk Exceptions; GPT-Rosalind, Claude Design, and Agentic Retail Deployments Highlighted

Major insurers including Berkshire Hathaway units, Travelers Group, and Chubb are excluding or restricting AI-related liability coverage, signaling growing concern over hard-to-model AI-driven claims. OpenAI introduced GPT-Rosalind, a domain-specific LLM fine-tuned for life sciences workflows, while Anthropic launched Claude Design for visual asset generation targeting non-designers. Additional items cover an AI-run San Francisco retail store exposing agentic system limitations, Wall Street banks cutting junior roles via AI deployment, and Anthropic's continued engagement with the Trump administration despite prior Pentagon restrictions.